Triple
T21694398
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Centre for Drug Safety |
E535462
|
entity |
| Predicate | collaboratesWith |
P37
|
FINISHED |
| Object | Norwegian Medicines Agency |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Norwegian Medicines Agency | Statement: [Centre for Drug Safety, collaboratesWith, Norwegian Medicines Agency]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Norwegian Medicines Agency Context triple: [Centre for Drug Safety, collaboratesWith, Norwegian Medicines Agency]
-
A.
Norwegian Medicines Agency
chosen
The Norwegian Medicines Agency is Norway’s national regulatory authority responsible for the approval, monitoring, and safe use of medicines and related health products.
-
B.
Norwegian Directorate of Health
The Norwegian Directorate of Health is a national government agency responsible for implementing health policy, issuing professional guidelines, and supporting the healthcare system in Norway.
-
C.
Finnish Medicines Agency
The Finnish Medicines Agency is Finland’s national authority responsible for regulating and supervising medicines and pharmaceutical safety.
-
D.
Norwegian Institute of Public Health
The Norwegian Institute of Public Health is Norway’s national public health agency responsible for disease surveillance, health research, and providing evidence-based advice to authorities and the public.
-
E.
Norwegian Medicines Act
The Norwegian Medicines Act is a key piece of Norwegian legislation that regulates the production, approval, distribution, and use of medicinal products to ensure their quality, safety, and proper control.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e0c46a6ee481908836e1420fb78c9b |
completed | April 16, 2026, 11:13 a.m. |
| NER | Named-entity recognition | batch_69ef9b79336081909000ceaa86f6aed3 |
completed | April 27, 2026, 5:23 p.m. |
Created at: April 16, 2026, 6:45 p.m.